ebomi
Colour theme
Sign in
Insider · CIK 0001664281

Parmar Kush

CIK 0001664281 Name as filed on the most recent filing

Filed as Parmar Kush (46)

100 transaction lines · from 46 filings · filed 2018-11-20 to 2026-08-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

44 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-06-03 S, Open-market sale Rallybio CorpRLYB 629,113, disposed Open Form 4 filing 0001209191-22-034860
2022-05-23 S, Open-market sale Rallybio CorpRLYB 2 lines 1,300,000, disposed Open Form 4 filing 0001209191-22-031969
2022-02-08 S, Open-market sale Rallybio CorpRLYB 2 lines 2,740,500, disposed Open Form 4 filing 0001209191-22-008579
2022-01-11 P, Open-market purchase CinCor Pharma, Inc.CINC 2 lines 7,520,000, acquired Open Form 4 filing 0001209191-22-003205
2021-11-16 S, Open-market sale Vor Biopharma Inc.VOR 2 lines 5,059,802, disposed Open Form 4 filing 0001209191-21-065656
2021-11-02 P, Open-market purchase Entrada Therapeutics, Inc.TRDA 5,000,000, acquired Open Form 4 filing 0001104659-21-134772
2021-11-01 S, Open-market sale Cabaletta Bio, Inc.CABA 2 lines 3,835,000, disposed Open Form 4 filing 0001209191-21-062716
2021-09-07 S, Open-market sale Cabaletta Bio, Inc.CABA 6,062,500, disposed Open Form 4 filing 0001209191-21-055343
2021-08-02 P, Open-market purchase Rallybio CorpRLYB 7,999,992, acquired Open Form 4 filing 0001209191-21-049823
2021-04-27 P, Open-market purchase Impel Neuropharma IncIMPL 8,625,000, acquired Open Form 4 filing 0001209191-21-029136
2021-02-09 P, Open-market purchase Vor Biopharma Inc.VOR 2 lines 9,999,990, acquired Open Form 4 filing 0001209191-21-008888
2021-01-12 S, Open-market sale Cabaletta Bio, Inc.CABA 2 lines 1,105,000, disposed Open Form 4 filing 0001209191-21-003268
2021-01-08 S, Open-market sale Cabaletta Bio, Inc.CABA 2 lines 3,926,000, disposed Open Form 4 filing 0001209191-21-003268
2020-12-29 S, Open-market sale Akouos, Inc.AKUS 2 lines 8,460,000, disposed Open Form 4 filing 0001209191-20-065779
2020-12-22 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 6,410,000, disposed Open Form 4 filing 0001209191-20-065305
2020-12-14 S, Open-market sale Homology Medicines, Inc.FIXX 4 lines 6,125,915, disposed Open Form 4 filing 0001209191-20-063907
2020-12-10 S, Open-market sale Cabaletta Bio, Inc.CABA 2 lines 4,395,500, disposed Open Form 4 filing 0001209191-20-063298
2020-10-05 S, Open-market sale Aprea Therapeutics, Inc.APRE 4,427,500, disposed Open Form 4 filing 0001104659-20-113186
2020-06-30 P, Open-market purchase Akouos, Inc.AKUS 4,999,989, acquired Open Form 4 filing 0001104659-20-080570
2020-06-16 S, Open-market sale Aprea Therapeutics, Inc.APRE 3 lines 4,662,000, disposed Open Form 4 filing 0001209191-20-037714
2020-06-11 S, Open-market sale Aprea Therapeutics, Inc.APRE 2 lines 7,044,412, disposed Open Form 4 filing 0001209191-20-036845
2020-05-19 S, Open-market sale Aprea Therapeutics, Inc.APRE 2 lines 8,963,250, disposed Open Form 4 filing 0001209191-20-031545
2019-10-29 P, Open-market purchase Cabaletta Bio, Inc.CABA 4,999,995, acquired Open Form 4 filing 0001104659-19-058504
2019-10-07 P, Open-market purchase Aprea Therapeutics, Inc.APRE 4,999,995, acquired Open Form 4 filing 0001104659-19-053617
2019-05-16 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 13,204,050, disposed Open Form 4 filing 0001104659-19-030565
2018-12-10 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 405,029, disposed Open Form 4 filing 0001104659-18-072618
2018-11-23 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 594,709, disposed Open Form 4 filing 0001104659-18-070149
2018-11-16 S, Open-market sale Homology Medicines, Inc.FIXX 2 lines 10,623,180, disposed Open Form 4 filing 0001104659-18-069432

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 5
  • Open-market sale 39
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. PARMAR KUSH, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001664281

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.